Probenecid, an FDA-approved medication having broad antiviral properties that’s primarily used to treat gout, can help combat not only SARS-CoV-2 infection but also other common and deadly respiratory viruses like RSV and flu, a study published in Nature’s Scientific Reports has found.
The research from the University of Georgia is expected to offer hope for a viable therapeutic to combat the disease that has claimed more than 4 million lives worldwide.
Probenecid is already widely available in the U.S. The drug has been on the market for over 40 years and has minimal side effects.
“There’s really nothing out there to safely fight these viruses,” said Ralph Tripp, lead author of the study and GRA Eminent Scholar of Vaccine and Therapeutic Studies in UGA’s College of Veterinary Medicine. “This antiviral works for all RNA respiratory viruses we tested, including SARS-CoV-2. RSV, coronavirus and flu all circulate in the same season. Bottom line is you can potentially reduce infection and disease using this one oral drug.”
Viruses work by co opting a person’s own cells to replicate and produce more of the virus. Probenecid blocks that replication process, keeping the virus from infecting the individual’s cells.
Although the drug would primarily be used after a person is positive for the virus, the prophylactic findings mean people with known exposures could also potentially take the drug to prevent getting sick.
The current go-to treatments for seriously ill COVID-19 patients, remdesivir and monoclonal antibodies, can only be given through an IV. And by the time a COVID patient needs them, it’s often too late.
“These treatments have seen some effectiveness against SARS-CoV-2, but they’re very expensive and very hard to come by,” Tripp said. “In reality, there are only a handful of options that can actually be used because of the cost, restricted IV usage, and lack of access. That’s not very useful to the world.”
Probenecid, on the other hand, is widely available. Primary care physicians could prescribe a pill to patients, and they could pick it up at their local drugstore.
Repurposing drugs that are already approved to work against one problem is common. For example, remdesivir was originally intended to fight the Ebola virus, but when it showed some promise in fighting the coronavirus, it was enlisted to battle COVID-19.
In addition to preventing illness before it starts, probenecid may also potentially increase the efficacy of other treatments. Probenecid is already used to up the potency of some antibiotics, so it’s possible the medication could work in conjunction with other COVID-19 treatments as well.